4baseCare Bags ₹38 Cr To Close Series B Round At ₹128 Cr
by Team Inc42 · Inc42SUMMARY
- The startup plans to continue deploying the freshly raised funds to fuel the expansion of its genomics laboratory globally and scale its AI-driven precision oncology platform
- Founded in 2018, 4baseCare leverages advanced genomics, bioinformatics, and AI to develop personalised oncology (cancer-related) care for patients
- According to Inc42 data, the homegrown healthtech market is projected to become a $37 Bn opportunity by 2030